Heart Failure Clinical Trials

Find Heart Failure Clinical Trials Near You

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

Randomized double-blind placebo-controlled crossover study design

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Clinical diagnosis of heart failure

• No plan for titration/change of heart failure medical or device therapies during the study period.

• Absence of non-elective hospitalizations in the previous 2 months.

• At optimal volume status by symptoms, exam, and dry weight.

• Serum potassium ≤ 5.0 mmol/L

• Serum sodium ≥ 130 milliequivalents/ liter (mEq/L)

• Hemoglobin ≥8 g/dL

• Age \>18 years

• Objective evidence of diuretic resistance to a 10mg bumetanide challenge (screening visit may occur under this protocol or HIC2000032328 or HIC2000034315) defined as:

‣ FENa \<10% and total sodium output \<150mmol

⁃ And at least one of the following criteria:

• Chronic home furosemide dose greater than or equal to 80mg furosemide equivalents

∙ eGFR \< 60ml/min

∙ Serum chloride \<100mmol/L

∙ FENa \<5% and total sodium output \<75mmol on the 2 hour

Locations
United States
Connecticut
Yale University
RECRUITING
New Haven
Contact Information
Primary
Veena Rao, PHD
veena.s.rao@yale.edu
2037373571
Time Frame
Start Date: 2024-07-24
Estimated Completion Date: 2029-03-01
Participants
Target number of participants: 50
Treatments
Active_comparator: Ammonium chloride
Participants will be randomized to ammonium chloride vs placebo. On Day 0 and 1, the participant will take ammonium chloride or placebo 75 mmol twice daily.~On Day 2, the participant will take ammonium chloride 150 mmol or placebo once
Placebo_comparator: Placebo
Participants will be randomized to ammonium chloride vs placebo. On Day 0 and 1, the participant will take ammonium chloride or placebo 75 mmol twice daily.~On Day 2, the participant will take ammonium chloride 150 mmol or placebo once
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Yale University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.